NASDAQ: OABI
Omniab Inc Stock

$3.81+0.17 (+4.67%)
Updated Feb 14, 2025
OABI Price
$3.81
Fair Value Price
N/A
Market Cap
$461.06M
52 Week Low
$3.10
52 Week High
$6.55
P/E
-6.15x
P/B
1.58x
P/S
21.22x
PEG
N/A
Dividend Yield
N/A
Revenue
$20.41M
Earnings
-$63.02M
Gross Margin
100%
Operating Margin
-373.44%
Profit Margin
-308.8%
Debt to Equity
0.14
Operating Cash Flow
-$45M
Beta
0.27
Next Earnings
Mar 18, 2025
Ex-Dividend
N/A
Next Dividend
N/A

OABI Overview

Avista Public Acquisition Corp. II is a "blank check" company formed to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar combinations with one or more businesses. The company is the second special purpose acquisition company sponsored by Avista Acquisition LP II. It targets healthcare companies. AHPA was incorporated in 2021 and is based in New York, NY.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine OABI's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
OABI
Ranked
#105 of 561

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important OABI news, forecast changes, insider trades & much more!

OABI News

Overview

Due Diligence Score

Industry Average (23)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how OABI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

OABI is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
OABI is good value based on its book value relative to its share price (1.58x), compared to the US Biotechnology industry average (4.77x)
P/B vs Industry Valuation
OABI is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more OABI due diligence checks available for Premium users.

Valuation

OABI fair value

Fair Value of OABI stock based on Discounted Cash Flow (DCF)

Price
$3.81
Fair Value
-$3.72
Undervalued by
202.45%
OABI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

OABI price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-6.15x
Industry
-169.22x
Market
37.92x

OABI price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
1.58x
Industry
4.77x
OABI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

OABI's financial health

Profit margin

Revenue
$4.2M
Net Income
-$16.4M
Profit Margin
-392.4%
OABI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
OABI's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$331.6M
Liabilities
$39.8M
Debt to equity
0.14
OABI's short-term assets ($66.61M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OABI's short-term assets ($66.61M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OABI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$6.6M
Investing
$4.4M
Financing
$8.6M
OABI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

OABI vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
OABIC$461.06M+4.67%-6.15x1.58x
VALN$463.27M-14.38%-61.76x1.98x
AKBAC$464.73M-0.47%-9.26x-9.22x
CMPXC$465.05M-2.03%-9.39x3.36x
ABVX$465.70M+3.21%-2.05x3.35x

Omniab Stock FAQ

What is Omniab's quote symbol?

(NASDAQ: OABI) Omniab trades on the NASDAQ under the ticker symbol OABI. Omniab stock quotes can also be displayed as NASDAQ: OABI.

If you're new to stock investing, here's how to buy Omniab stock.

What is the 52 week high and low for Omniab (NASDAQ: OABI)?

(NASDAQ: OABI) Omniab's 52-week high was $6.55, and its 52-week low was $3.10. It is currently -41.82% from its 52-week high and 22.9% from its 52-week low.

How much is Omniab stock worth today?

(NASDAQ: OABI) Omniab currently has 121,012,583 outstanding shares. With Omniab stock trading at $3.81 per share, the total value of Omniab stock (market capitalization) is $461.06M.

Omniab stock was originally listed at a price of $9.86 in Oct 11, 2016. If you had invested in Omniab stock at $9.86, your return over the last 8 years would have been -61.36%, for an annualized return of -11.21% (not including any dividends or dividend reinvestments).

How much is Omniab's stock price per share?

(NASDAQ: OABI) Omniab stock price per share is $3.81 today (as of Feb 14, 2025).

What is Omniab's Market Cap?

(NASDAQ: OABI) Omniab's market cap is $461.06M, as of Feb 17, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Omniab's market cap is calculated by multiplying OABI's current stock price of $3.81 by OABI's total outstanding shares of 121,012,583.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.